{
    "2020-03-03": [
        [
            {
                "time": "",
                "original_text": "天风证券: 把握后疫情时代医药产业趋势 关注一季报预期高增长板块",
                "features": {
                    "keywords": [
                        "后疫情时代",
                        "医药产业",
                        "一季报",
                        "高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "创新ETF密集上市 中证创新药产业指数有哪些投资机会？",
                "features": {
                    "keywords": [
                        "创新ETF",
                        "中证创新药",
                        "投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物疫苗板块走强",
                "features": {
                    "keywords": [
                        "生物疫苗",
                        "板块走强"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "17股获买入评级 最新: 中国平安",
                "features": {
                    "keywords": [
                        "买入评级",
                        "中国平安"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物（002007）深度：血制龙头、疫苗中坚＆单抗新兵",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "血制龙头",
                        "疫苗",
                        "单抗新兵"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【东吴医药】华兰生物2019年业绩快报点评：静丙增长明显，4价流感疫苗实现高速增长",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "静丙",
                        "4价流感疫苗",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "186股获券商买入评级，天康生物目标涨幅达77.28%",
                "features": {
                    "keywords": [
                        "券商买入评级",
                        "天康生物",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "账上躺百亿资金，A股龙头为何纷纷融资？",
                "features": {
                    "keywords": [
                        "百亿资金",
                        "A股龙头",
                        "融资"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】医药行业周报（20200301）：新冠疫情全球蔓延升级，维持医药长期看好观点",
                "features": {
                    "keywords": [
                        "新冠疫情",
                        "全球蔓延",
                        "医药行业",
                        "长期看好"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}